Home / Resources and Insights / New Continuous Hydrogenation Manufacturing Line
New Continuous Hydrogenation Manufacturing Line
Less than 1 min read time
We’ve just added two new continuous hydrogenation lines at our Changshu site, with a throughput of 200 kg/day.
Site Spotlight: We’ve just added two new continuous hydrogenation lines at our Changshu site, with a throughput of 200 kg/day. Our continuous hydrogenation process supports a wide range of reactions, including nitro group reduction, debenzylation, decarbonylation, double bond reduction, and cyanide reduction, scalable from kilograms to metric tons.
Our Changshu site, specializing in producing early intermediates, is conveniently located within a 2-hour drive from our two API manufacturing sites in Changzhou and Shanghai.
Related Reading
WuXi STA Forms Strategic Partnership with Beta Pharma
STA will Accelerate Process R&D and Manufacturing of Late Phase and Commercial Targets STA Pharmaceutical Co., Ltd., (WuXi STA) –...
New Blow-Fill-Seal Aseptic Filling Line
New Capability Spotlight: We just launched a new Blow-Fill-Seal (BFS) aseptic filling line at our drug product site in Wuxi...
WuXi STA launched a new PSD-4 spray dryer at our Taixing API manufacturing facility in China
WuXi STA continues to expand spray-dried dispersion (SDD) capabilities with the launch of a new PSD-4 spray dryer at our Taixing API...